Qube Research & Technologies LTD Connect Biopharma Holdings LTD Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Qube Research & Technologies LTD holds 46 shares of CNTB stock, worth $57. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46
Previous 46
-0.0%
Holding current value
$57
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CNTB
# of Institutions
13Shares Held
2.98MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.04MShares$2.53 Million2.22% of portfolio
-
Ubs Oconnor LLC Chicago, IL511KShares$633,2690.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny212KShares$263,2520.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$128,8240.0% of portfolio
-
Keudell32.2KShares$39,9280.01% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $68.2M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...